By Kevin Doherty

You sat down last Tuesday to update your fee schedule for the first time in three years. You opened the spreadsheet. You looked at your initial visit fee — $375 — and you considered raising it to $425. Your hand hovered over the cell. You thought about the patient you saw that afternoon who had told you the fee was “a lot.” You thought about the two prospects last month who had asked if you had “anything more affordable.” You thought about how you’d feel if someone heard $425 and decided not to book. You closed the spreadsheet without making the change.

The flinch you felt in that moment is the single biggest structural limit on the revenue of most functional medicine practices. Not the market. Not the economics. Not the competition. The flinch. The specific internal tightening that happens when a genuinely competent practitioner tries to raise her fees to match the value of the work she’s actually delivering, and something in her contracts around the act of asking for it.

Here’s the clinical reality underneath that flinch. You’re doing 60-90 minute initial intakes that would cost $600-$1,200 at any other specialty practice. You’re reviewing lab panels most physicians don’t order and don’t know how to read. You’re designing treatment protocols that require ongoing judgment across months of case management. You’re fielding between-visit messages, interpreting new lab results, adjusting protocols, coordinating with other providers. Your work is specialty work. Your pricing is still in the generalist tier because the flinch hasn’t let you move it.

This article is about how pricing actually works for comprehensive functional medicine care, what the specific tiers look like, how to build program pricing that matches the work, and how to present that pricing to prospects so it’s accepted rather than negotiated. It’s also about the psychology underneath — because the pricing change that matters most isn’t the number in the spreadsheet, it’s the internal shift that makes the number feel correct rather than presumptuous.

Why Visit-Fee Pricing Structurally Caps the Practice

A practice running visit-fee economics is bounded by a specific math problem. Each hour of practitioner time produces one billable unit. Scale comes from either more hours (which hits a human limit) or higher per-hour rates (which hits a market and psychological limit). Both ceilings are real and close together.

A practitioner charging $375 for initials and $175 for follow-ups, seeing 6 new patients monthly plus 20-25 follow-ups weekly at an average billable hour structure, generates roughly $18K-$24K per month in clinical revenue. Adding a dispensary margin takes it to $22K-$32K. Take out overhead (rent, staff, software, labs that don’t pass through) and the practitioner clears $10K-$18K monthly pre-tax. This is the visit-fee ceiling. The practitioner is working 50+ hours a week, clinical pace degrading, and the numbers don’t scale past this no matter how many operational improvements are made.

The same practitioner running a comprehensive program model generates different economics. A $7,500 six-month program, sold to 3-4 new patients monthly, generates $22K-$30K in program revenue per month on top of ongoing revenue from existing patients. The annual program revenue alone runs $270K-$360K. With existing patient retention revenue added and smaller overhead ratios because administrative load is concentrated at program-enrollment rather than per-visit, the same practitioner clears $15K-$28K monthly pre-tax on similar or lower clinical hours.

This is the program-pricing math. It’s not a small improvement over visit-fee economics. It’s a different economic model entirely.

The reason the program model works isn’t that patients are paying more for the same work. They’re paying for a defined outcome — a six-month clinical process with a clear structure, an explicit scope, and a transformation the practitioner is committing to work toward. The work itself is usually similar to what the practitioner is already doing under visit-fee billing. What changes is the frame around the work — and the frame is what the prospect is actually buying.

The Market Reality of FM Pricing

Before getting into the psychology, it’s worth naming the actual market data. Functional medicine pricing has moved substantially over the past five years, and most individual practitioners are still pricing at levels that lag the market by 30-60%.

The current landscape:

Initial consultations at established FM clinics run $350-$950 for 60-90 minute visits, with premium practices charging $1,000-$1,500 for deeper initial workups. Mid-tier practitioners charging $250-$400 are pricing below market in most regions.

Follow-up visits run $175-$450 depending on length and practitioner positioning. The $125-$175 tier that was common five years ago is now associated with community and accessibility-focused practices rather than specialty practices.

Comprehensive 3-6 month programs run $5,000-$9,500 at the mid-tier, $8,000-$15,000 at the specialty tier, and $15,000-$30,000 at the premium tier. The $3,000-$5,000 program range has largely disappeared as a viable specialty tier — practices operating here are usually competing with community-FM pricing without the community-FM volume to make the math work.

Annual membership models run $300-$700 monthly for baseline access, $700-$1,500 monthly for higher-touch access, and $2,000-$5,000 monthly for concierge-style access. Annual equivalents range $3,600-$60,000.

Premium specialty programs focused on complex niches (post-Lyme chronic illness, advanced longevity protocols, pediatric PANS/PANDAS, fertility specialization) commonly reach $20,000-$45,000 for 6-12 months of comprehensive care.

These numbers aren’t aspirational. They’re the market. A practitioner charging $2,800 for a six-month comprehensive program in 2026 is pricing at 2019 levels, and the prospects she’s attracting at that pricing tend to be the ones who are shopping on price rather than evaluating on clinical fit. The patients who convert best at higher pricing tiers are usually not the same patients who would convert at lower pricing tiers. The lower pricing is attracting a specific patient population that isn’t the one the specialty work is built for.

The Program Pricing Architecture

A well-structured comprehensive program has seven components that together produce the price. Each component is worth real money; the program as a whole is worth meaningfully more than the sum of the components because the integration itself has value.

The initial workup

A 90-120 minute first visit that includes detailed history, symptom mapping, prior lab review, differential thinking, and the initial clinical plan. On its own this visit would cost $500-$1,200 at market rates for specialty consultation of this depth.

Targeted lab testing

Comprehensive functional testing appropriate to the niche — specialty panels that conventional workups don’t typically include. Depending on the niche, total lab cost runs $600-$2,500, typically with a modest practitioner markup built into the program price or passed through at cost. The clinical value of the lab testing isn’t the testing itself — it’s the clinical interpretation that follows, which is part of the practitioner’s work.

Follow-up visit cadence

A defined schedule of follow-up visits across the program — typically 4-8 sessions of 45-75 minutes over the 3-6 month arc. At market follow-up rates ($250-$450 per visit for specialty work), the follow-up visits alone represent $1,000-$3,600 in clinical time.

Protocol design and iteration

The ongoing work between visits — reviewing new lab results, adjusting supplementation, modifying dietary and lifestyle protocols, coordinating with other providers, documenting clinical observations. This background clinical work is typically 2-5 hours per patient across the program. At practitioner hourly rates, this represents $500-$1,500 of additional clinical value that visit-fee billing doesn’t capture.

Between-visit support

Secure messaging, portal access for questions, occasional brief check-ins. Patients in comprehensive programs need the option to reach the practitioner between appointments, and including this in the program price eliminates the billing friction of per-message charges. Typical time commitment is 1-3 hours per patient across the program.

Patient education and resources

Protocols, recipes, practitioner-curated educational materials, supplement reference guides, symptom tracking tools. Most comprehensive programs include a resource library specific to the patient population. The cost of building this library is amortized across patients, so the per-patient cost is modest, but the perceived value to patients is substantial.

The clinical outcome

The meta-component that holds all the others together — the specific clinical transformation the program is designed to produce. This isn’t billable separately. It’s what justifies the whole program price being higher than the sum of its components. A six-month program that resolves a pattern a patient has been carrying for years is worth more than six individual months of loosely-connected care, even when the clinical time is identical.

The sum of components at market rates typically totals $4,500-$9,000 for a mid-tier program. The program price at $7,500-$12,000 reflects the integration value above the sum. Premium programs add specialty elements (advanced testing, additional practitioners, specialty protocols) that push the component sum higher and the program price correspondingly.

Setting the Specific Number

The specific program price is a function of three variables: the practitioner’s positioning authority, the regional market, and the program’s scope. A practitioner positioned as the specialist in a narrow clinical niche can command higher pricing than a generalist FM practitioner with similar clinical skills, because the positioning itself is part of what the patient is paying for. The positioning spoke covers the specific moves that create positioning authority.

A practical framework for setting initial program pricing:

Starting tier (for practitioners newer to program pricing): $4,500-$6,500 for a 4-6 month program. Serves practitioners who are transitioning from visit-fee economics and need pricing that produces clear conversion wins in the first 3-6 months of the new model. Usually held for 6-12 months, then raised.

Standard specialty tier: $7,000-$10,000 for a 6-month comprehensive program. The working tier for most established FM practices with clear niche positioning. This is where the economics become meaningfully different from visit-fee pricing without requiring ultra-premium positioning.

Premium specialty tier: $11,000-$18,000 for a 6-12 month program. Requires strong positioning, demonstrated clinical outcomes in a specific niche, and usually a waiting list or referral-driven patient flow. Practitioners who reach this tier are typically 2-4 years into building the full nine-layer architecture.

Concierge or elite tier: $20,000-$45,000 annually for high-touch ongoing care. A smaller segment of practices — typically serving executive, athletic, or complex-case populations — operates at this tier with deeply integrated care relationships and minimal patient volume.

Most practitioners transitioning from visit-fee to program pricing should start at the standard specialty tier ($7,000-$10,000). Starting lower makes the program math fail to meaningfully differ from visit-fee economics, defeating the purpose of the transition. Starting higher produces prospect resistance before the practitioner has built the positioning authority to support premium pricing. The standard tier is the best starting point for most practices.

Presenting the Price So It’s Accepted

The price presentation matters as much as the price itself. The same $8,400 program presented two different ways produces meaningfully different conversion rates. Four specific presentation principles separate programs that convert at 55-75% from programs that convert at 25-40%.

Present the program first, the price second

The prospect should understand what they’re receiving before they hear the number. A program description that runs 2-4 minutes (in consultation) or 600-900 words (on a sales page) that specifically names the scope, inclusions, timeline, and expected clinical arc — followed by the price — converts dramatically better than a price mentioned early that the prospect then evaluates before understanding what’s being offered.

The order matters because prospects evaluate price against the most recent information they have. When the price appears first, they evaluate it against nothing. When it appears after the full program description, they evaluate it against the accumulated value of what’s been described. The same price lands completely differently in the two contexts.

Name the price as a single figure, not a breakdown

“The program is $8,400” converts better than “The program includes 8 visits at $350 each, plus $1,800 in labs, plus $3,800 in support and resources — so $8,400 total.” The breakdown invites haggling on components; the single figure invites evaluation of the whole. Once the prospect is thinking about whether lab fees could be reduced or whether they really need the support component, the frame has shifted from program evaluation to component negotiation. That shift damages conversion.

The one exception is payment structure — offering 2-3 payment options (pay in full, 3 payments, monthly) is valuable. That’s logistics, not component haggling, and it increases conversion modestly.

Present pricing without apology or qualification

The language matters. “The program is $8,400” converts well. “The program is $8,400, which I know sounds like a lot, but here’s why it’s actually worth it” converts worse, because the practitioner’s own apology signals that the price is unreasonable. Prospects take their pricing cues from the practitioner’s confidence in the price. Confident presentation normalizes the number; apologetic presentation pathologizes it.

This is where the internal resistance covered later in this article matters most. Practitioners who haven’t resolved their own discomfort with the price communicate that discomfort in every presentation, and prospects respond accordingly. The work of the price presentation is partly the language, mostly the practitioner’s internal stance.

Name what’s excluded

Counterintuitively, naming what the program doesn’t include builds trust in the inclusions. “The program price doesn’t cover pharmacy prescriptions beyond what’s in the initial protocol, additional specialty testing beyond the included panel, or emergency visits for acute issues.” This framing signals honest scope — the practitioner isn’t hiding limitations. Programs that oversell inclusions and then surprise patients with additional costs damage trust significantly; programs that name the edge of the scope up front build it.

The Pricing Resistance Practitioners Face

Underneath most underpriced FM practices is a specific form of practitioner resistance. It almost never presents as “I’m afraid to charge more.” It presents as any of several adjacent concerns that feel legitimate in the moment.

The common forms the resistance takes:

“I don’t want to price out patients who need this work.” The ethical framing. Sounds principled. Is actually almost always an incomplete analysis, because pricing below market produces fewer converted patients (not more, paradoxically — under-pricing attracts price-shoppers who don’t convert well), unsustainable practice economics, and eventual practice closure or burnout. The practitioner who underprices to “help more people” often ends up seeing fewer people over the arc of her career because the practice doesn’t sustain. A portion of access can be preserved through deliberate sliding-scale or pro bono offerings that don’t affect the core pricing.

“I need to prove myself before I can charge that much.” The credentialing fallacy. The belief that authority must precede pricing. In practice, the opposite is closer to true — pricing is itself one of the signals that creates authority in patient perception, and a practitioner charging at specialty tiers is perceived as a specialist in ways that a practitioner charging at generalist tiers is not. Waiting to prove oneself before pricing accordingly produces a loop where the lower pricing is the thing preventing the authority from developing.

“My market can’t support that pricing.” The market fallacy. Occasionally accurate in genuinely economically-constrained regions, but mostly inaccurate. The patient population with willingness and ability to invest in comprehensive care exists in almost every metro market — they’re just not the patients currently shopping the practice’s lower-priced tier. The market that can’t support specialty pricing is usually the market the practice is currently recruiting from, not the market the practice could recruit from with different positioning and pricing.

“I’m not sure my work is worth that much.” The imposter dynamic. The most common and least-named resistance. The practitioner has been in clinical work for years, has produced meaningful outcomes in hundreds of cases, has accumulated specific expertise that most practitioners don’t have — and still doesn’t quite believe her work is worth what similar practitioners in her position charge. This belief is usually wrong on the facts. It’s also usually the controlling factor in the pricing decision.

The self-aware practitioner’s imposter syndrome piece covers the specific pattern — the form of self-doubt that affects genuinely competent practitioners and manifests most visibly in pricing decisions. This is the dynamic to understand and work with, not ignore. Practices that address the imposter layer consistently move through pricing transitions successfully. Practices that treat pricing as purely a strategic decision and ignore the internal dynamic tend to make the strategic decision and then fail to execute on it — the fee schedule changes, but the price gets quietly discounted in every consultation until the practice is effectively still at the old pricing.

The honest work of a pricing transition is the internal work alongside the strategic work. The spreadsheet change is the surface. The internal shift that lets the practitioner hold the price without flinching is the actual move.

Payment Structure and Policy

Once the program price is set, payment structure is a secondary but real decision.

Payment in full at program start. Typically discounted 5-10% from the split-payment price. Simplifies administration, removes collection friction, and creates commitment. About 30-50% of program patients choose this option when it’s offered. Recommended as the default option.

Split payment (2-3 installments). Most common choice. Typically two payments (at start and midpoint) or three payments (at start, month 2, month 4). No discount from full price. About 40-60% of program patients choose this option.

Monthly payments across the program. Less common but available in some practices. Simplifies affordability for some patients but introduces collection risk and administrative load. About 10-20% of program patients choose this option when offered. Recommended as optional rather than primary.

External financing (Affirm, CareCredit, ALPHAEON). Allows patients to finance the program over 6-24 months through a third-party lender. The practice receives full payment; the patient makes monthly payments to the lender. Increases conversion modestly for price-sensitive prospects, with the tradeoff of processing fees (typically 8-15%). Worth offering as an option, not featuring as primary.

Refund policy. Most established FM programs offer partial refunds for patients who exit early (typically prorated minus a program enrollment fee). No-refund policies damage trust and often cost more in lost conversions than they save in retained revenue. A clear, reasonable refund policy increases program signup rates because prospects are less afraid of committing.

Pricing for Existing Patients During Transition

A practice transitioning from visit-fee to program pricing has to handle the existing patient base carefully. Several approaches work; the specific choice depends on practice philosophy and patient demographics.

Grandfather existing patients at current pricing. Existing patients continue paying visit fees; new patients move to program pricing. This is the most relationship-preserving approach and the least revenue-optimizing. Makes sense for smaller practices with strong patient relationships that would be damaged by forced transition.

Offer existing patients optional program enrollment. Existing patients can continue visit-fee care or opt into a program. Usually phrased as an opportunity (“if you’d like deeper comprehensive care, we’re now offering it as a structured program”) rather than a requirement. About 15-35% of existing patients typically opt in, producing meaningful revenue lift without forcing the transition.

Transition all patients to program pricing. The most direct approach. All patients — existing and new — move to the program model. Typically loses 20-40% of existing patient base during the transition, which is uncomfortable but produces the cleanest new-model economics going forward. Makes sense for practices that have built enough new-patient acquisition capacity to absorb the attrition.

Create a maintenance tier for stable patients. Separate pricing tier for patients in long-term stable care who don’t need comprehensive program work. Typically priced at visit-fee rates or slightly above, keeps these patients accessible without cluttering the program model with stable-case work. Useful for practices with long-tenured patient bases.

There’s no universally correct approach. The transition itself is a one-time event; the practice’s long-term economics depend mostly on the new-patient pricing model, which is why most of this article focuses there.

The Numbers Most Practices Miss

Several pricing-adjacent metrics reveal whether the pricing is actually working, beyond the obvious “are we enrolling program patients.”

Average revenue per patient over 12 months. In a well-structured program model, this runs $8,000-$14,000 including program, post-program maintenance, and supplement dispensary revenue. Practices stuck at $2,500-$4,500 are likely running hybrid economics where the program isn’t the primary offering or the pricing tier is too low.

Consultation-to-program conversion rate. Target 55-75% for well-qualified prospects arriving through strategic lead magnets and email sequences. Rates below 40% suggest either upstream pipeline issues or pricing that’s misaligned with positioning (either too high for current authority or too low to be taken seriously).

Program completion rate. Patients who complete the full program arc, as defined by the program structure. Healthy practices run 75-90% completion. Below 60% suggests program structure issues — scope too broad, timeline too long, or outcomes not well-matched to the patient population. Above 95% may indicate overly conservative scope that’s not challenging the clinical work.

Re-enrollment rate. Patients who sign up for a second comprehensive program after completing the first. In niches with chronic management components (perimenopause, autoimmune, complex chronic conditions), re-enrollment rates of 30-50% are normal and contribute meaningfully to revenue. In acute-arc niches (acute post-infection recovery, preconception), re-enrollment is naturally lower because the initial program addresses the presenting issue.

Patient-initiated referral rate. The percentage of program patients who refer at least one new patient during or after their program. In well-positioned practices with strong clinical outcomes, this runs 40-70%. Below 25% suggests either clinical outcomes issues or patient experience issues — patients don’t refer practices they didn’t love.

Tracking these metrics quarterly gives the practice visibility into whether the pricing model is actually working. The Practice Operating System covers the measurement stack that makes these metrics accessible without consuming administrative time.

When Pricing Isn’t the Problem

Not every practice struggling with enrollment has a pricing problem. Several common issues masquerade as pricing issues while actually being something else:

Positioning issues. Generic positioning produces prospects who evaluate on price because they have nothing else to evaluate on. Raising prices without fixing positioning produces lower enrollment, not higher. Positioning work is upstream. Covered in the positioning spoke.

Consultation conversion issues. Prospects arrive interested, book consultations, and don’t convert — but the issue is in the consultation itself, not the price. Covered in the consultation conversion spoke.

Lead quality issues. The prospect pool is dominated by wellness-curious browsers who were never going to invest in comprehensive care. The issue is upstream lead qualification, not pricing. Covered in the lead magnets spoke.

Trust issues. Prospects don’t yet believe the practitioner can deliver the outcome. No amount of pricing adjustment solves this. Trust builds through content, case outcomes, professional referrals, and time. Covered in the perception-shift content spoke and the authority content spoke.

Diagnosing the actual constraint is worth doing before making pricing moves. A practice with a positioning problem and a pricing problem solved by raising prices produces worse outcomes. A practice with a pricing problem alone solved by raising prices produces better outcomes. The diagnosis matters.

The Shift That Makes It Possible

The pricing transition is most successfully made by practitioners who stop thinking of pricing as an extraction from the patient and start thinking of it as the appropriate frame around the work. A $9,000 program isn’t the practitioner taking $9,000 from the patient. It’s the practitioner committing six months of specialty clinical attention to the patient’s complex case, at a price that reflects the actual scope of the work being done.

The patient at that price is paying for a specific transformation, delivered by a specific practitioner, through a specific program structure, with a specific clinical outcome expected. Most patients who invest $9,000 in a comprehensive program produce $20,000-$80,000 in downstream health value — avoided ER visits, avoided specialist costs, avoided pharmaceutical escalation, regained productivity, regained quality of life. The $9,000 is a leveraged investment on the patient’s side. That frame, held honestly, produces the practitioner’s internal capacity to present pricing without flinching.

The Practitioner’s Dilemma names the underlying frame — the tension between the volume-throughput economics that most healthcare runs on and the depth-arc economics that comprehensive care actually requires. Pricing is where that tension surfaces most visibly. A practitioner who resolves the pricing question has usually resolved, by that point, the larger dilemma about what kind of practice she’s building. The pricing decision is the one that reveals the answer.

The next layer downstream is the consultation itself — where the pricing is presented, the prospect decides, and the program begins. That work is covered in the consultation conversion spoke. The upstream work that makes premium pricing possible — positioning, niche, clinical authority — is in the positioning spoke. The full nine-layer architecture is in the practice growth hub.

Frequently Asked Questions